.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Chubb
Express Scripts
Boehringer Ingelheim
Teva
Covington
Deloitte
Merck
Farmers Insurance

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,715,485

« Back to Dashboard

Which drugs does patent 6,715,485 protect, and when does it expire?


Patent 6,715,485 protects ONZETRA XSAIL and is included in one NDA.

This patent has one hundred and forty-six patent family members in twenty-six countries.

Summary for Patent: 6,715,485

Title: Nasal delivery device
Abstract:A delivery device (20, 22) for and a method of delivering a substance to the nasal airway (1) of a subject, in particular the posterior region of the nasal airway, the delivery device comprising: a closure unit for causing the closure of the oropharyngeal velum of the subject; and a delivery unit for delivering a gas flow entraining a substance to one of the nostrils of the subject at such a driving pressure as to flow around the posterior margin of the nasal septum and out of the other nostril of the subject, wherein the delivery unit comprises a nosepiece (30, 40, 58, 82, 102, 132) which includes an outlet through which the gas flow is in use delivered to the one nostril and a sealing member for sealing the one nostril to the outlet such as in use to prevent the escape of the gas flow through the one nostril.
Inventor(s): Djupesland; Per Gisle (Oslo, NO)
Assignee: OptiNose AS (Oslo, NO)
Application Number:09/700,532
Patent Claim Types:
see list of patent claims
Delivery; Device;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Avanir Pharms
ONZETRA XSAIL
sumatriptan succinate
POWDER;INHALATION206099-001Jan 27, 2016RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,715,485

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9904906Mar 3, 1999
United Kingdom9911686May 19, 1999
PCT Information
PCT FiledMarch 03, 2000PCT Application Number:PCT/IB00/00273
PCT Publication Date:September 08, 2000PCT Publication Number: WO00/51672

Non-Orange Book Patents for Patent: 6,715,485

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,119,932Nasal delivery device► Subscribe
9,072,857Nasal delivery device► Subscribe
7,347,201Nasal delivery devices► Subscribe
7,841,337Breath-actuated nasal delivery device► Subscribe
7,975,690Nasal devices► Subscribe
8,522,778Nasal devices► Subscribe
8,511,303Nasal delivery devices► Subscribe
8,555,877Nasal delivery device► Subscribe
8,596,278Nasal devices► Subscribe
8,555,878Nasal delivery device► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 6,715,485

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Turkey200102563► Subscribe
Slovenia1180378► Subscribe
Slovenia1161274► Subscribe
Russian Federation2337720► Subscribe
Russian Federation2003128878► Subscribe
Russian Federation2319513► Subscribe
Russian Federation2004100276► Subscribe
Russian Federation2258538► Subscribe
Portugal1180378► Subscribe
Portugal1161274► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Express Scripts
Queensland Health
Dow
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
Cipla
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot